<DOC>
	<DOCNO>NCT02368340</DOCNO>
	<brief_summary>Hermansky-Pudlak Syndrome ( HPS ) rare genetic disease associate oculocutaneous albinism , bleeding , granulomatous colitis , pulmonary fibrosis subtypes , include HPS-1 , HPS-2 , HPS-4 . Pulmonary fibrosis cause shortness breath progressive decline lung function . In HPS patient at-risk subtypes , almost adult eventually develop fatal pulmonary fibrosis unless undergo lung transplantation . The purpose study identify early measurable pulmonary disease activity individual at-risk HPS pulmonary fibrosis . The study also aim develop biomarkers aid understanding cause HPS pulmonary fibrosis facilitate rapid conduct therapeutic trial HPS patient mild pulmonary disease future .</brief_summary>
	<brief_title>A Longitudinal Study Hermansky-Pudlak Syndrome Pulmonary Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Hermanski-Pudlak Syndrome</mesh_term>
	<criteria>Individuals age 1290 year confirm diagnosis HPS define verification reduce absent platelet dense granule electron microscopy and/or genetic diagnosis Ability provide inform consent , consent parent/guardian assent minor Statuspost lung transplantation Perceived unsuitability participation study opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>